Senator Win Gatchalian issued a stern warning to the telecommunications companies against attempts to further delay the already forestalled implementation of the Mobile Number Portability Act (MNPA), saying that they will be meted out with appropriate penalties.
Senator Win Gatchalian called on colleagues to have the bill seeking to lift the validity period of prepaid load credits for phones and internet services tackled in the Senate.
Senator Win Gatchalian said that reports on consumer products with hazardous chemicals that continue to flood online platforms should set off alarm bells to concerned authorities.
Senator Win Gatchalian said the booming online business and growing paperless transactions following the lockdowns across the country due to the coronavirus pandemic has spawned the need to further safeguard against fraudulent traders and sale of counterfeit items.
Given the radical change in the country’s business climate with more online businesses registering, Senator Win Gatchalian is pushing for the ‘Internet Transactions Act’ to put in place strict regulations to protect consumers from unethical and unscrupulous business practices on the internet.
Senator Win Gatchalian criticized groups calling for a revolutionary government in the midst of a deep and prolonged crisis due to the COVID-19 pandemic.
Senator Win Gatchalian expresses support for the Bicameral Conference Committee’s adopted version to reduce the process of application for telecommunication companies to build more cell towers.
To build the much-needed information and communications technology (ICT) infrastructure the country needs amid the COVID-19 pandemic, Senator Win Gatchalian urged the government to ensure that Republic Act 11032 or the Ease of Doing Business and Efficient Government Service Delivery Act of 2018 is in full force.
Senator Win Gatchalian welcomes President Rodrigo Duterte’s directives on various measures to push forward the economic recovery cited on Monday’s State of the Nation Address (SONA), amid the country’s battle against the coronavirus disease (COVID-19).
